tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AU:CU6 Stock Latest News

Clarity flags more prostate cancer patients with no detectable disease in SECuRE trial
Company AnnouncementsClarity flags more prostate cancer patients with no detectable disease in SECuRE trial
19h ago
CU6
Clarity Advances Late-Stage Radiopharmaceutical Pipeline on Strong Cash Base
PremiumCompany Announcements
Clarity Advances Late-Stage Radiopharmaceutical Pipeline on Strong Cash Base
25d ago
CU6
Clarity’s SECuRE Prostate Cancer Trial Clears Safety Review and Advances Toward Phase III
PremiumCompany Announcements
Clarity’s SECuRE Prostate Cancer Trial Clears Safety Review and Advances Toward Phase III
1M ago
CU6
Clarity Pharmaceuticals Options Lapse, Simplifying Capital Structure
PremiumCompany Announcements
Clarity Pharmaceuticals Options Lapse, Simplifying Capital Structure
2M ago
CU6
Clarity’s Prostate Cancer Imaging Data Secures Prime Spot at Major European Urology Congress
PremiumCompany Announcements
Clarity’s Prostate Cancer Imaging Data Secures Prime Spot at Major European Urology Congress
2M ago
CU6
Clarity Wins FDA Backing for Phase III Trial of Cu-64 SARTATE in Neuroendocrine Tumours
PremiumCompany AnnouncementsClarity Wins FDA Backing for Phase III Trial of Cu-64 SARTATE in Neuroendocrine Tumours
2M ago
CU6
Clarity Pharmaceuticals Showcases Superior Imaging Agent at ASCO-GI 2026
Premium
Company Announcements
Clarity Pharmaceuticals Showcases Superior Imaging Agent at ASCO-GI 2026
3M ago
CU6
Clarity Pharmaceuticals Issues Unquoted Equity Securities
Premium
Company Announcements
Clarity Pharmaceuticals Issues Unquoted Equity Securities
3M ago
CU6
Clarity Pharmaceuticals Issues Unquoted Equity Securities to Employees
PremiumCompany Announcements
Clarity Pharmaceuticals Issues Unquoted Equity Securities to Employees
3M ago
CU6
JPMorgan Chase & Co. Ceases Substantial Holding in Clarity Pharmaceuticals
PremiumCompany Announcements
JPMorgan Chase & Co. Ceases Substantial Holding in Clarity Pharmaceuticals
3M ago
CU6
Clarity Pharmaceuticals Announces Director’s Change in Securities Interest
PremiumCompany Announcements
Clarity Pharmaceuticals Announces Director’s Change in Securities Interest
3M ago
CU6
Clarity Pharmaceuticals Director Acquires Additional Options
PremiumCompany Announcements
Clarity Pharmaceuticals Director Acquires Additional Options
3M ago
CU6
Clarity Pharmaceuticals Announces Director’s Interest Change
PremiumCompany AnnouncementsClarity Pharmaceuticals Announces Director’s Interest Change
3M ago
CU6
Clarity Pharmaceuticals Secures Strong Shareholder Support at AGM
Premium
Company Announcements
Clarity Pharmaceuticals Secures Strong Shareholder Support at AGM
3M ago
CU6
Clarity Pharmaceuticals Strengthens Market Position with Successful Capital Raise and Advancements in Oncology Pipeline
Premium
Company Announcements
Clarity Pharmaceuticals Strengthens Market Position with Successful Capital Raise and Advancements in Oncology Pipeline
3M ago
CU6
Clarity Pharmaceuticals Highlights Investment Risks and Forward-Looking Statements at AGM
PremiumCompany Announcements
Clarity Pharmaceuticals Highlights Investment Risks and Forward-Looking Statements at AGM
3M ago
CU6
JPMorgan Chase & Co. Ceases Substantial Holding in Clarity Pharmaceuticals
PremiumCompany Announcements
JPMorgan Chase & Co. Ceases Substantial Holding in Clarity Pharmaceuticals
3M ago
CU6
Clarity Pharmaceuticals Issues New Shares Following Option Exercise
PremiumCompany Announcements
Clarity Pharmaceuticals Issues New Shares Following Option Exercise
3M ago
CU6
Clarity Pharmaceuticals Expands Market Presence with New Securities Quotation
PremiumCompany Announcements
Clarity Pharmaceuticals Expands Market Presence with New Securities Quotation
3M ago
CU6
JPMorgan Chase & Co. Ceases to be Substantial Holder in Clarity Pharmaceuticals
PremiumCompany AnnouncementsJPMorgan Chase & Co. Ceases to be Substantial Holder in Clarity Pharmaceuticals
4M ago
CU6
Clarity Pharmaceuticals Advances Prostate Cancer Diagnostic Study
Premium
Company Announcements
Clarity Pharmaceuticals Advances Prostate Cancer Diagnostic Study
4M ago
CU6
Clarity Pharmaceuticals’ Prostate Cancer Study: A Potential Breakthrough?
Premium
Company Announcements
Clarity Pharmaceuticals’ Prostate Cancer Study: A Potential Breakthrough?
4M ago
CU6

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >